Cns Pharmaceuticals Inc [CNSP] stock is trading at $0.13, down -9.20%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CNSP shares have gain 8.36% over the last week, with a monthly amount drifted -5.44%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cns Pharmaceuticals Inc [NASDAQ: CNSP] stock has seen the most recent analyst activity on December 28, 2020, when Ladenburg Thalmann downgraded its rating to a Neutral. Previously, Ladenburg Thalmann started tracking the stock with Buy rating on August 24, 2020, and set its price target to $11.
Cns Pharmaceuticals Inc [CNSP] stock has fluctuated between $0.10 and $137.50 over the past year. Currently, Wall Street analysts expect the stock to reach $0.5 within the next 12 months. Cns Pharmaceuticals Inc [NASDAQ: CNSP] shares were valued at $0.13 at the most recent close of the market. An investor can expect a potential return of 284.62% based on the average CNSP price forecast.
Analyzing the CNSP fundamentals
Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at -2512.76%, Pretax Profit Margin comes in at -2510.77%, and Net Profit Margin reading is -2510.77%. To continue investigating profitability, this company’s Return on Assets is posted at -6.47, Equity is 4.29 and Total Capital is 3.72. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1206 points at the first support level, and at 0.1090 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1464, and for the 2nd resistance point, it is at 0.1606.
Ratios To Look Out For
For context, Cns Pharmaceuticals Inc’s Current Ratio is 0.31. Further, the Quick Ratio stands at 0.31, while the Cash Ratio is 0.22.
Transactions by insiders
Recent insider trading involved Gumulka Jerzy, Director, that happened on Feb 01 ’24 when 33333.0 shares were purchased. Director, Evans Carl Anthony completed a deal on Feb 01 ’24 to buy 33333.0 shares. Meanwhile, Chief Financial Officer Downs Christopher bought 66666.0 shares on Feb 01 ’24.
